European Archives - Page 941 of 1059 - European Medical Journal

Pathophysiology and Treatment of HIDS

At the American College of Rheumatology Annual Meeting, topic of interest is the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)

Canakinumab in the treatment of tumour necrosis factor receptor-associated periodic syndrome (TRAPS)

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…

Treatment Strategies for TRAPS

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen Lachmann…

Treatments for Patients with CAPS

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Jasmin Kuemmerle…

EMJ

Structure of Coronavirus Defence Offers Clues to Treatment

DECIPHERING the structure of a key protein in the coronavirus HKU1, a member of a family of deadly viruses, has provided a promising avenue for…

EMJ

First 3D Printed ‘Sneezometer’ Opens Doors to Diagnosis

PIONEERING use of 3D printing technology has enabled the development of simple, non-intrusive, and cost-effective spirometry for the diagnosis of…

EMJ

EULAR Crowdsources Inspirational Stories to Educate the World about Rheumatic and Musculoskeletal Diseases

Sofia, Bulgaria (15 April 2016): EULAR and the Standing Committee of PARE (People with Arthritis/Rheumatism) has launched ‘The Future In Your Hands’…

EMJ

UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy

LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…

EMJ

Celyad Will Present Its NKR-2 Immuno-Oncology Clinical Program at 2016 ASCO Annual Meeting

Mont-Saint-Guibert, Belgium: Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…

EMJ

Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…